Page 4,976«..1020..4,9754,9764,9774,978..4,9905,000..»

Neon Roberts' mother says treatment has affected his co-ordination

Posted: Published on August 14th, 2013

Sally Roberts, 38, lost legal battle to stop son receiving radiotherapy Doctors argued that her son would die within three months if he did not She said he was 'feeling rubbish', despite doctors saying he's on mend By Daily Mail Reporter PUBLISHED: 17:16 EST, 13 August 2013 | UPDATED: 17:56 EST, 13 August 2013 The mother of an eight-year-old boy receiving radiotherapy for a brain tumour has said his spirit has been crushed by the treatment. Sally Roberts told ITVs Daybreak programme that Neons co-ordination had been affected by the cancer treatment and her son was 'feeling pretty rubbish', despite doctors telling her he was on the mend. Ms Roberts, a New Zealander living in Brighton, East Sussex, appeared on the television show ahead of a documentary, Youre Killing My Son: The Mum Who Went On The Run, which will be shown on Channel 4 tonight. Sally Roberts told ITV's Daybreak programme that Neon's co-ordination had been affected by the cancer treatment and her son was 'feeling pretty rubbish', despite doctors telling her he was on the mend Footage shown on Daybreak showed Neons father Ben telling documentary-makers that his wife, from whom he is separated, kidnapped his son and … Continue reading →

Posted in MS Treatment | Comments Off on Neon Roberts' mother says treatment has affected his co-ordination

Results of ‘liberation treatment’ study for MS three years away

Posted: Published on August 14th, 2013

Researchers doing in the first national study of the controversial liberation treatment for multiple sclerosis wont reach final conclusions about its safety and effectiveness until 2016, says Dr. Anthony Traboulsee, the studys principal investigator, adding that his team wants to do open, honest research. Researchers doing the first national study of the controversial liberation treatment for multiple sclerosis wont reach final conclusions about its safety and effectiveness until 2016, says the studys principal investigator. In an interview this week, Dr. Anthony Traboulsee said he and his team are trying to safely expedite research into the so-called CCSVI treatment, pioneered by Italian vascular surgeon Paolo Zamboni, which uses angioplasty to open blocked veins in MS patients necks. Theres such a lot of interest in it, Traboulsee said. People want to know the answers yesterday. But though hundreds of MS patients have expressed interest in participating in the two-year study, the actual selection of study subjects has been slow. Before patients can be accepted into the study, they must be assessed to ensure they really do have MS, are healthy enough to participate and fully understand what the study is about, Traboulsee said. They also need documentation that shows narrowing in their … Continue reading →

Posted in MS Treatment | Comments Off on Results of ‘liberation treatment’ study for MS three years away

MS Treatment Options Growing, Raising New Hope

Posted: Published on August 14th, 2013

Newswise MAYWOOD, Il. After decades of research, multiple sclerosis patients are seeing a rapid expansion of effective new treatment options, according to a review article in the journal Neurologic Clinics. Recently approved drugs, as well as medications being tested in clinical trials, appear to be more effective than the first generation of new drugs introduced in the 1990s. But the new medications also may present complex side effect profiles, according to the articles author, Dr. Matthew McCoyd of Loyola University Medical Center. McCoyd is a neurologist who specializes MS. Today, we stand on the precipice of a changing landscape in MS therapies, McCoyd wrote. Several new medications have been approved by the U.S. Food and Drug Administration in the United States, and several more are awaiting a final decision or are completing phase 3 clinical trials. The question facing physicians, patients and families is not just a question of remedies, but how to navigate the increasingly complex effective treatment options for MS. The first effective drug (interferon beta-1B) for the treatment of relapsing forms of MS was approved in the early 1990s. In recent years, several other effective new drugs have been approved, including fingolimod (Gilenya), teriflunomide (Aubagio) and BG-12 … Continue reading →

Posted in MS Treatment | Comments Off on MS Treatment Options Growing, Raising New Hope

Mapping replacement of dead cells in the intestine uncovers critical stem cell pool

Posted: Published on August 14th, 2013

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript. In order to enable it, please see these instructions. 1 hour ago Normally quiescent Bmi1-positive intestinal stem cells (ISCs) (left) undergo increased division in the event of drug-induced cell death (right). Blue staining indicates successful lineage tracing of new cells arising from ISC proliferation and maturation. Credit: 2013 Elsevier Stem cells play a critical role in replacing various cells within the intestine, but can also become drivers for colorectal cancer. The composition of these stem cell reservoirs has been debated. New research from Dmitry Bulavin of the A*STAR Institute of Molecular and Cell Biology has now clarified the organization of this tissue, yielding insights that should steer future cancer research. Bulavin and co-workers had previously identified a population of '+4' cellsdenoting their position within the intestinal epitheliumthat appeared to contain intestinal stem cells (ISCs)2. They determined that activation of certain oncogenes rapidly kills these cells via a mechanism called apoptosis, a critical safeguard against cancerous growth. Accordingly, mice with a genetic mutation that increased the apoptotic response of these cells were also protected against intestinal tumors. However, subsequent findings from another team … Continue reading →

Posted in Stem Cell Research | Comments Off on Mapping replacement of dead cells in the intestine uncovers critical stem cell pool

Glowing Bunnies: Why They Matter

Posted: Published on August 14th, 2013

Their creation is part of genetic research aimed at mass-producing medication and treating hereditary illness. And they seem to be in good health, don't worry. The transgenic bunnies were born last week. They are expected to live long, productive rabbit lives. They are not evil; they just glow bright green under a black light. They do not portend apocalypse, but rather a potential for great good. The road to their creation began years ago. Dr. Stefan Moisyadi works with transposing DNA vectors at the University of Hawaii School of Medicine, where glowing mice were created in the 1980s. Now he's at the head of the rabbit projectthough this time the birth took place in Istanbul, as part of a collaboration with Turkish researchers. The idea is that scientists inject genetic material into rabbit embryos, and they want to see that it becomes a part of their genetic makeup. The glowing green is not an end in itself, but a marker that their technique is working. The protein that creates the glow comes from jellyfish DNA (which was injected into the rabbit embryo). Moisyadi told Hawaii local news channel KHON, "These rabbits are like a light bulb glowing, like an LED … Continue reading →

Comments Off on Glowing Bunnies: Why They Matter

DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register

Posted: Published on August 14th, 2013

By: Jet Villa, InterAksyon.com August 13, 2013 8:42 AM InterAksyon.com The online news portal of TV5 MANILA, Philippines - The Department of Health (DOH) has given all health facilities practicing stem cell therapy and companies importing and producing stem cell products untilAug. 31to apply for accreditation and product registration, respectively. Nick Lutero, director of the DOH-Bureau of Health Facilities and Services, said it will be considered illegal for facilities to do stem cell procedures if they fail to comply with the requirement. Papatigil namin ang pag-conduct ng therapy. For those still continuing to practice, I think we have sufficient laws, particularly on the illegal practice of medicine. They could be criminally liable, he said in a chance interview. Lutero lamented that only five hospitals have applied for registration although the DOH had issued the guidelines on this since March. We have done preliminary visits sa mga hospitals na ito at mukang based sa initial inspection, merong sufficient compliance sa mga facilities, he said. Companies importing and producing stem cell products, on the other hand, should apply for registration with the Food and Drug Administration, an agency attached to the DOH. Products that will not be applied for registration will also … Continue reading →

Comments Off on DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register

Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results

Posted: Published on August 14th, 2013

SAN DIEGO, Aug. 13, 2013 /PRNewswire/ --Ambit Biosciences (AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced results for the second quarter and six months ended June 30, 2013. The company will host a conference call today to provide an operational update and discuss financial results, its first as a public company. "The second quarter was transformative for Ambit. We successfully completed our initial public offering, which put us on solid financial footing to continue the clinical development of quizartinib, our lead drug candidate," said Michael Martino, president and Chief Executive Officer. "Our primary goal is to make this potentially important new therapy available to patients with acute myeloid leukemia (AML), who are in need of better treatment options." Second Quarter Highlights and Recent Events Quizartinib Program Update The Company has completed preliminary top line analyses of the Phase 2b clinical trial of quizartinib. This trial studied 30mg and 60mg doses administered daily to FLT3 ITD positive patients 18 years and older who were relapsed or refractory to second line treatment or a hematopoietic stem cell transplant (HSCT). Data from the top line efficacy analysis at both … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results

Stem cells turned into cancer-killing immune cells

Posted: Published on August 14th, 2013

T cells, colored blue here, move in to attack. In addition to fighting off invaders that arrive from outside the body, the immune system is also able to identify cells that have gone bad inside the body. Even though cancer cells look a lot like normal ones, immune cells can often tell the differenceenough that people who receive long-term treatments of immunosuppressive drugs have a higher incidence of cancer. But the immune system clearly has its limits, or cancer wouldn't be a problem.Cancer cells evolve ways to avoid detection or use the immune system's own signals to tamp down its activity.A number of researchers have been looking for ways to reestablish the immune system's superiority, boosting it in a way that it once again clears out cancer cells. One option for doing so has been to simply boost the cells that already recognize a tumor by isolating them and growing them in large numbers in culture. This doesn't consistently work, however, as it can be hard to identify and isolate tumor-specific immune cells. A team of researchers has figured out a way of taking stem cells, converting them into immune cells, and directing them to attack one type of cancer. … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Stem cells turned into cancer-killing immune cells

Osiris shares rocket, company details Grafix study

Posted: Published on August 14th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix Beyond … Continue reading →

Comments Off on Osiris shares rocket, company details Grafix study

Medical groups get support over bid for free stem cell

Posted: Published on August 14th, 2013

TWENTY-TWO medical organizations pushing for the free stem cell treatment in the country on Tuesday got a shot in the arm as the co-chairperson of the Philippine Health Research Ethics Board (PHREB) expressed agreement to their position. In a weekly forum in Quezon City, PHREB co-chairperson Dr. Marita Reyes said it is only right that the patient undergoing stem cell therapy will not be charged, especially since the amount involved is millions of pesos. "The one who will carry the most risk should not be made to pay," opined Reyes. Over the weekend, 22 medical organizations said that stem cell therapy should be given free based on ethical standards. "When stem cell is given under a clinical study, it is unethical to make patients pay for the treatment. The cost of treatment should be shouldered by the sponsor of the study," said the organizations in their position paper. However, Department of Health (DOH) Secretary Enrique Ona rejected this. Ona said, the country cannot afford to make service providers shoulder the cost of the stem cell treatment. This was despite his admission that the government has yet to approve any type of stem cell treatment and that those practiced here can … Continue reading →

Comments Off on Medical groups get support over bid for free stem cell

Page 4,976«..1020..4,9754,9764,9774,978..4,9905,000..»